Medication info

Armix Injection

Prescription medicationInjections
Ingredient · strength
L-Histidine›0.24g / 100mLL-Cysteine Hydrochloride Hydrate›0.02g / 100mLL-Valine›0.56g / 100mLL-Isoleucine›0.59g / 100mLGlycine›1.19g / 100mLL-Methionine›0.45g / 100mLL-Leucine›0.77g / 100mLL-Threonine›0.34g / 100mLL-Tryptophan›0.13g / 100mLL-Phenylalanine›0.48g / 100mLL-Lysine Acetate›0.87g / 100mLL-Serine›0.5g / 100mLL-Arginine›0.81g / 100mLL-Alanine›0.6g / 100mLL-Proline›0.95g / 100mL
Manufacturer / importer
Daehan Pharmaceutical Co., Ltd.
Appearance
A colorless to slightly yellow transparent solution contained in a multilayer film plastic container or a glass container for infusion, in a polypropylene aqueous injection container.
Packaging
Bottle - 100 milliliters/bottle, Bottle - 180 milliliters/bottle, Bottle - 200 milliliters/bottle, Bottle - 250 milliliters/bottle, Bag - 100 milliliters/bag, Bag - 250 milliliters/bag
Approval status
Active

MFDS item code 199203486 · Notified 1992.04.28

Summary

Main use
Improvement of nutritional status (e.g., malnutrition and hypoproteinemia) through amino acid supplementation
Who uses it
Adults · Children
Adult dosage
○ Adults: Administer by infusion up to a maximum of 1~1.5 g of total amino acids per kg of body weight daily. ○ Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is preferred; in principle, infuse at a rate of 30~40 drops per minute.
Children's dosage
Adjust the dose and infusion rate for children, older adults, and patients with burns who have high protein requirements.

Ingredients

Manufacturer
Daehan Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of nutritional status (e.g., malnutrition and hypoproteinemia) through amino acid supplementation

  • Hypoproteinemia
  • malnutrition
View approved original text

The provision of amino acids is used to promote protein synthesis in the body and improve nutritional status in conditions of protein deficiency such as hypoproteinemia, malnutrition, and pre- and post-operative states.

Dosage and Administration

Adult dosage

○ Adults: Administer by infusion up to a maximum of 1~1.5 g of total amino acids per kg of body weight daily. ○ Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is preferred; in principle, infuse at a rate of 30~40 drops per minute.

Children's dosage

Adjust the dose and infusion rate for children, older adults, and patients with burns who have high protein requirements.

Precautions

This medication must be used strictly according to a doctor's instructions. It should not be used in patients at risk for hepatic coma or those with severe kidney dysfunction, those with nitrogen metabolism issues, patients with severe heart failure or pulmonary edema, those with very little or no urine output, patients with hypernatremia or hyperchloremia, those with alkalosis, or patients with a history of myocardial infarction. It should be administered with caution in patients with severe acidosis, congestive heart failure, edema due to sodium retention, hyperkalemia, or those with liver and kidney disorders. This medication contains sodium bisulfite, which may cause allergic reactions or asthma attacks in some patients, necessitating caution. During use, symptoms such as rash, nausea, vomiting, palpitations, and elevated blood pressure may occur, and in severe cases, discontinuation should be considered. Caution is required as metabolic acidosis or other serious side effects may occur with large or rapid administration. Patients with impaired kidney or liver function should have their conditions monitored frequently through blood tests and other means. Electrolyte balance must be carefully monitored during large dosages, as excessive administration can lead to metabolic alkalosis. Excess fluid administration should be avoided in patients with kidney disease, lung disease, or severe heart disease. Diabetic patients should frequently monitor their blood sugar levels while using this medication. Interactions may occur when used with other medications, so consultation with medical personnel is essential. Pregnant women should only use this medication when the therapeutic benefits outweigh the risks, as its safety has not been established. When administering to children, the concentration should be lower, and particularly for infants, frequent monitoring of blood ammonia levels is necessary. Elderly patients should have the administration rate slowed down and the dose adjusted due to decreased bodily function. This medication contains electrolytes, requiring monitoring of electrolyte balance during administration, which should be done slowly intravenously. The injection should be adjusted to body temperature, and preparation and management must be done under aseptic conditions. Do not use the solution if it has changed color or leaked before use, and it is advisable to use it within 24 hours when stored in refrigeration without opening the package. Check the measurement markings on the container accurately before use, and do not use damaged containers.

Side effects

  • Rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • rapid pulse
  • elevated blood pressure
  • acidosis
  • chills
  • fever
Show 27 more
  • headache
  • respiratory distress
  • respiratory arrest
  • shock
  • bronchospasm
  • uropathy
  • metabolic acidosis
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes
  • osmotic diuresis
  • dehydration
  • rebound hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin overload
  • electrolyte imbalance
  • pediatric hyperammonemia
  • elevated BUN
  • serum amino acid imbalance
  • metabolic alkalosis
  • systemic nitrogenemia
  • hyperammonemia
  • sensory loss
  • coma
  • anaphylactic shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and light exposure, ideally at room temperature between 1 and 30 degrees Celsius. Storing it this way helps to maintain the drug's effectiveness.

Appearance and packaging

Appearance

A colorless to slightly yellow transparent solution contained in a multilayer film plastic container or a glass container for infusion, in a polypropylene aqueous injection container.

Package unit

Bottle - 100 milliliters/bottle, Bottle - 180 milliliters/bottle, Bottle - 200 milliliters/bottle, Bottle - 250 milliliters/bottle, Bag - 100 milliliters/bag, Bag - 250 milliliters/bag

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.